Top

BMC Pediatrics

Published in:

Open Access 01-12-2021 | Mood Disorders | Research article

Stigma and psychological distress among pediatric participants in the FD/MAS Alliance Patient Registry

Author: Amanda Konradi

Published in: BMC Pediatrics | Issue 1/2021

Abstract

Background

Stigma, both enacted and internalized, is part of the illness experience of many chronic conditions / diseases and has been found to increase psychological distress, lower self-esteem, and impact social engagement lowering quality of life (QOL). Stigma among pediatric patients is of particular concern due to its potential impact on identity formation. Using patient data from the online FD/MAS Alliance Patient Registry (FDMASAPR), this study seeks to 1) determine levels of enacted and self-stigma in a pediatric population of fibrous dysplasia (FD) / McCune Albright syndrome (MAS) patients and 2) to explore the relationship between stigma and anxiety and depression.

Methods

This is a cross sectional analysis of deidentified self-report data from 18 pediatric patients. Key analytic variables include the Neuro-QOL stigma short form, the Hospital Anxiety and Depression Scale (HADS), diagnostic category and craniofacial involvement, and select demographics. Sample means and score distributions are examined. Bivariate relationships between stigma, anxiety and depression and patient’s personal and medical characteristics are established through analysis of variance and correlation.

Results

Composite stigma levels for FD/MAS pediatric patients were comparable to those of children with multiple sclerosis, epilepsy, and muscular dystrophy. Self-stigma was more frequently reported than enacted/felt stigma, but few patients indicated complete freedom from either type of stigma. Diagnosis was significantly related to self-stigma. Significant bivariate relationships were found between depression and enacted/felt and self-stigma and between anxiety and self-stigma.

Conclusions

This study establishes the illness experience of pediatric patients with FD / MAS is impacted by stigma and suggests they should be regularly screened for stigma and psychological distress. It supports the integration of clinical psychologists/ therapists in regular patient care, referral of families to advocacy organizations, and indicates that rare disease patient registries can be a useful tool in efforts to improve the QOL of patients.

Boyce A, Florenzano P, de Castro LF, Collins MT. Fibrous dysplasia/McCune-Albright syndrome. In: Gene reviews. Seattle: University of Washington; 2019. p. 1993–2020. https://www.ncbi.nlm.nih.gov/books/.

Kushchayeva YS, Kushchayev SV, Glushko TY, Tella SH, Teytelboym OM, Collins MT, et al. Fibrous dysplasia for radiologists: beyond ground glass bone matrix. Insights Imaging. 2018;9(6):1035–56. https://doi.org/10.1007/s13244-018-0666-6.

Utriainen P, Valta H, Björnsdottir S, Mäkitie O, Horemuzova E. Polyostotic fibrous dysplasia with and without McCune–Albright syndrome—clinical features in a Nordic pediatric cohort. Front Endocrinol. 2018;9:96. https://doi.org/10.3389/fendo.2018.00096.CrossRef

Kelly MH, Brillante B, Collins MT. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int. 2008;19(1):57–63. https://doi.org/10.1007/s00198-007-0425-x.CrossRefPubMed

Kelly MH, Brillante B, Kushner H, Gehron Robey P, Collins MT. Physical function is impaired but quality of life preserved in patients with fibrous dysplasia of bone. Bone. 2005;37(3):388–94. https://doi.org/10.1016/j.bone.2005.04.026.CrossRefPubMed

Burke A, Boyce AM, Collins MT. Fibrous dysplasia of bone: craniofacial and dental implications. Oral Dis. 2017;23(6):697–708. https://doi.org/10.1111/odi.12563.CrossRefPubMed

Konradi A. Treating the “illness” of Cherubism and craniofacial fibrous dysplasia: addressing the stigma of craniofacial difference. J Law Med Ethics. 2017;45(4):582–95. https://doi.org/10.1177/1073110517750598.CrossRef

Boyce AM, Burke A, Peck CC, DuFresne CR, Lee JS, Collins MT. Surgical management of polyostotic craniofacial fibrous dysplasia: long term outcomes and predictors for postoperative regrowth. Plast Reconstr Surg. 2016;137(6):1833–9. https://doi.org/10.1097/PRS.0000000000002151.CrossRefPubMedPubMedCentral

Macgregor FC. Facial disfigurement: problems and management of social interaction and implications for mental health. Aesthetic Plast Surg. 1990;14(1):249–57. https://doi.org/10.1007/BF01578358.CrossRefPubMed

10.

Thomas S. A phenomenological study of chronic pain. West J Nurs Res. 2000;22:683–705.PubMed

11.

Goffman E. Stigma: notes on the management of spoiled identity. New York: Touchstone; 1986.

12.

Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol. 2001;27:363–85.CrossRef

13.

Green S, Davis C, Karshmer E, Marsh P, Straight B. Living stigma: the impact of labeling, stereotyping, separation, status loss, and discrimination in the lives of individuals with disabilities and their families. Sociol Inq. 2005;75(2):197–215. https://doi.org/10.1111/j.1475-682X.2005.00119.x.CrossRef

14.

Bos AER, Pryor JB, Reeder GD, Stutterheim SE. Stigma: advances in theory and research. Basic Appl Soc Psychol. 2013;35:1–9.CrossRef

15.

Rao D, Choi SW, Victorson D, Bode R, Peterman A, Heinemann A, et al. Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI). Qual Life Res. 2009;18(5):585–95. https://doi.org/10.1007/s11136-009-9475-1.

16.

Corrigan PW, Watson AC. The paradox of self-stigma and mental illness. Clin Psychol Sci Pract. 2002;9:35–53.CrossRef

17.

Elkington KS, Hackler D, McKinnon K, Borges C, Wright ER, Wainberg ML. Perceived mental illness stigma among youth in psychiatric outpatient treatment. J Adolesc Res. 2012;27(2):290–317. https://doi.org/10.1177/0743558411409931.CrossRefPubMed

18.

Bonanno A, Esmaeli B. Cancer and facial disfigurement: reducing survivors’ stigma in social interaction. Clin J Oncol Nurs. 2012;41:153–9.CrossRef

19.

Roberts RM. Discrimination among adults with craniofacial conditions. J Craniofac Surg. 2014;25(1):77–81. https://doi.org/10.1097/SCS.0b013e3182a2e005.CrossRefPubMed

20.

Hanus SH, Bernstein NR, Kapp KA. Immigrants into society: children with craniofacial anomalies. Clin Pediatr (Phila). 1981;20(1):37–41. https://doi.org/10.1177/000992288102000105.CrossRef

21.

Strauss RP, Newell R, Marks I. “Only skin deep”: health, resilience, and craniofacial care. Cleft Palate Craniofac J. 2001;38(3):226–30. https://doi.org/10.1597/1545-1569_2001_038_0226_osdhra_2.0.co_2.CrossRefPubMed

22.

Crandall CS, Moriarty D, Pan AW, Chung L, Fife BL, Hsiung PC. Physical illness stigma and social rejection. Int J Rehabil Res. 2007;34:30 67; 235–83; 238.

23.

Fife BL, Wright ER. The dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer. J Health Soc Behav. 2000;41(1):50–67.

24.

Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta analysis. Soc Sci Med. 2010;71:2150–61.CrossRef

25.

Clement S, Brohan E, Thornicroft G, Slade M, Brohan E. Experiences of mental illness stigma, prejudice and discrimination: a review of measures. BMC Health Serv Res. 2010;10 Generic. http://proxy-ln.researchport.umd.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=edswsc&AN=000276564400002&site=eds-live&scope=site.

26.

Camp DL, Finlay WML, Lyons E. Is low self-esteem an inevitable consequence of stigma? An example from women with chronic mental health problems. Soc Sci Med. 2002;55:823–34.CrossRef

27.

Carlton-Ford S, Miller R, Nealeigh N, Sanchez N. The effects of perceived stigma and psychological over-control on the behavioural problems of children with epilepsy. Seizure. 1997;6(5):383–91. https://doi.org/10.1016/S1059-1311(97)80038-6.CrossRefPubMed

28.

Victorson D, Cavazos JE, Holmes GL, Reder AT, Wojna V, Nowinski C, et al. Validity of the Neurology Quality-of-Life (Neuro-QoL) measurement system in adult epilepsy. Epilepsy Behav. 2014;31:77–84. https://doi.org/10.1016/j.yebeh.2013.11.008.

29.

Mogensen L, Mason J. The meaning of a label for teenagers negotiating identity: experiences with autism spectrum disorder. Sociol Health Illn. 2015;37(2):255–69. https://doi.org/10.1111/1467-9566.12208.CrossRefPubMed

30.

Beaune L, Forrest CR, Keith T. Adolescents’ perspectives on living and growing up with Treacher Collins syndrome: a qualitative study. Cleft Palate Craniofac J. 2004;41(4):343–50. https://doi.org/10.1597/02-158.1.CrossRefPubMed

31.

Roerink SHPP, Wagenmakers MAEM, Wessels JF, Sterenborg RBTM, Smit JW, Hermus ARMM, et al. Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly. Pituitary. 2015;18(3):366–75. https://doi.org/10.1007/s11102-014-0583-8.

32.

Pandey N. Crouzon syndrome: a social stigma. BMJ Case Rep. 2012;2012:7242.

33.

Mendes Á, Sousa L, Sequeiros J, Clarke A. Discredited legacy: stigma and familial amyloid polyneuropathy in northwestern Portugal. Soc Sci Med. 2017;182:73–80. https://doi.org/10.1016/j.socscimed.2017.04.026.CrossRefPubMed

34.

Pascoe EA, Richman LS. Perceived discrimination and health: a meta-analytic review. Psychol Bull. 2009;135(4):531–54. https://doi.org/10.1037/a0016059.CrossRefPubMedPubMedCentral

35.

Scambler G. Health-related stigma. Sociol Health Illn. 2009;31(3):441–55. https://doi.org/10.1111/j.1467-9566.2009.01161.x.CrossRefPubMed

36.

van der Beek KM, Bos I, Middel B, Wynia K. Experienced stigmatization reduced quality of life of patients with a neuromuscular disease: a cross-sectional study. Clin Rehabil. 2013;27(11):1029–38. https://doi.org/10.1177/0269215513487234.CrossRefPubMed

37.

Myung G, Harada ND, Fong SL, Aquino-Beaton C., Fang, MA. Characterization of social stigma in rheumatic diseases and correlation with quality of life and medication adherence. Arthritis & Rheumatology. 2014;66:S921–S922.

38.

Aspinall CL. Do I make you uncomfortable? Reflections on using Suegery to reduce the distress of others. In: Parens E, editor. Surgically shaping children: technology, ethics and the pursuit of normality. Baltimore: Johns Hopkins University Press; 2008. p. 13–28.

39.

Roberts RM, Shute R. Living with a craniofacial condition: development of the craniofacial experiences questionnaire (CFEQ) for adolescents and their parents. J Pediatr Psychol. 2011;48:727–35.

40.

Edwards TC, Patrick DL, Topolski TD, Aspinall CL, Mouradian WE, Speltz ML. Approaches to craniofacial-specific quality of life assessment in adolescents. Cleft Palate Craniofac J. 2005;42(1):19–24. https://doi.org/10.1597/03-097.2.1.CrossRefPubMed

41.

Geirdal AØ, Saltnes SS, Storhaug K, Åsten P, Nordgarden H, Jensen JL. Living with orofacial conditions: psychological distress and quality of life in adults affected with Treacher Collins syndrome, cherubism, or oligodontia/ectodermal dysplasia—a comparative study. Qual Life Res. 2015;24(4):927–35. https://doi.org/10.1007/s11136-014-0826-1.CrossRefPubMed

42.

Patrick DL, Topolski TD, Edwards TC, Aspinall CL, Kapp-Simon KA, Rumsey NJ, et al. Measuring the quality of life of youth with facial differences. Cleft Palate Craniofac J. 2007;44(5):538–47. https://doi.org/10.1597/06-072.1.

43.

Hartog K, Hubbard CD, Krouwer AF, Thornicroft G, Kohrt BA, Jordans MJD. Stigma reduction interventions for children and adolescents in low- and middle-income countries: systematic review of intervention strategies. Soc Sci Med. 2020;246:112749. https://doi.org/10.1016/j.socscimed.2019.112749.CrossRefPubMed

44.

McMaugh A. En/countering disablement in school life in Australia: children talk about peer relations and living with illness and disability. Disabil Soc. 2011;26(7):853–66. https://doi.org/10.1080/09687599.2011.618740.CrossRef

45.

Bakula DM, Sharkey CM, Perez MN, Espeleta HC, Hawkins M, Chaney JM, et al. The role of stigma in the relationship between illness intrusiveness and adjustment in adolescents and young adults: a path model. J Pediatr Psychol. 2019;44(5):611–9. https://doi.org/10.1093/jpepsy/jsz004.

46.

Gamwell KL, Baudino MN, Bakula DM, Sharkey CM, Roberts CM, Grunow JE, et al. Perceived illness stigma, thwarted belongingness, and depressive symptoms in youth with inflammatory bowel disease (IBD). Inflamm Bowel Dis. 2018;24(5):960–5. https://doi.org/10.1093/ibd/izy011.

47.

Roberts CM, Gamwell KL, Baudino MN, Grunow JE, Jacobs NJ, Tung J, et al. The contributions of illness stigma, health communication difficulties, and thwarted belongingness to depressive symptoms in youth with inflammatory bowel disease. J Pediatr Psychol. 2020;45(1):81–90.

48.

Kranke D, Jackson SE, Taylor DA, Landguth J, Floersch J. ‘I’m loving life’: adolescents’ empowering experiences of living with a mental illness. Qual Soc Work. 2015;14(1):102–18. https://doi.org/10.1177/1473325013510545.CrossRef

49.

Majoor BCJ, Andela CD, Bruggemann J, van de Sande MAJ, Kaptein AA, Hamdy NAT, et al. Determinants of impaired quality of life in patients with fibrous dysplasia. Orphanet J Rare Dis. 2017;12(1):80. https://doi.org/10.1186/s13023-017-0629-x.

50.

Majoor BCJ, Andela CD, Quispel CR, Rotman M, Dijkstra PDS, Hamdy NAT, et al. Illness perceptions are associated with quality of life in patients with fibrous dysplasia. Calcif Tissue Int. 2018;102(1):23–31. https://doi.org/10.1007/s00223-017-0329-5.

51.

Rotman M, Andela CD, Majoor BCJ, Dijkstra PDS, Hamdy NAT, Kaptein AA, et al. Passive coping strategies are associated with more impairment in quality of life in patients with fibrous dysplasia. Calcif Tissue Int. 2018;103(5):469–75. https://doi.org/10.1007/s00223-018-0441-1.

52.

Hagelstein-Rotman M, Genders SW, Andela CD, Dijkstra S, Majoor BCJ, Notting IC, et al. Patients with isolated craniofacial dysplasia report better quality of life compared with those with craniofacial dysplasia and extracranial involvement. Ophthalmic Plast Reconstr Surg. 2020;36(3):292–7. https://doi.org/10.1097/IOP.0000000000001536.

53.

Burke AB, Leroux BG, Konradi A. Quality of life and stigma outcomes in the surgical treatment of craniofacial fibrous dysplasia (Poster); 2020.

54.

Burke A, Konradi A. To operate or not to operate: quality of life outcomes in craniofacial fibrous dysplasia (Poster). 2020. https://www.eventscribe.com/2020/AAOMS-Annual/posters/posterthumbview.asp.

55.

Fibrous Dysplasia Foundation Patient Registry. www.fdmasregistry.org. Accessed 10 Dec 2020.

56.

Neuro QOL - Quality of life in Neurological Disorders - Scoring Manual, Version 2.0 March 2015. http://www.healthmeasures.net/images/neuro_qol/Neuro_QOL_Scoring_Manual_Mar2015.pdf. Accessed 30 Dec 2019.

57.

Lai J-S, Nowinski C, Victorson D, Bode R, Podrabsky T, McKinney N, et al. Quality-of-life measures in children with neurological conditions: pediatric Neuro-QOL. Neurorehabil Neural Repair. 2012;26(1):36–47. https://doi.org/10.1177/1545968311412054.

58.

Molina Y, Choi SW, Cella D, Rao D. The stigma scale for chronic illnesses 8-item version (SSCI-8): development, validation and use across neurological conditions. IntJ Behav Med. 2013;20(3):450–60. https://doi.org/10.1007/s12529-012-9243-4.CrossRef

59.

Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29–34..

60.

Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale an updated literature review. J Psychosom Res. 2002;52(2):69–77. https://doi.org/10.1016/S0022-3999(01)00296-3.CrossRefPubMed

61.

Cosco TD, Doyle F, Ward M, McGee H. Latent structure of the hospital anxiety and depression scale: a 10-year systematic review. J Psychosom Res. 2012;72(3):180–4. https://doi.org/10.1016/j.jpsychores.2011.06.008.CrossRefPubMed

62.

White D, Leach C, Sims R, Atkinson M, Cottrell D. Validation of the hospital anxiety and depression scale for use with adolescents. Br J Psychiatry. 1999;175(5):452–4. https://doi.org/10.1192/bjp.175.5.452.CrossRefPubMed

63.

Jörngården A, Wettergen L, von Essen L. Measuring health-related quality of life in adolescents and young adults: Swedish normative data for the SF-36 and the HADS, and the influence of age, gender, and method of administration. Health Qual Life Outcomes. 2006;4(1):91. https://doi.org/10.1186/1477-7525-4-91.CrossRefPubMedPubMedCentral

64.

Saez-Flores E, Tonarely NA, Barker DH, Quittner AL. Examining the stability of the hospital anxiety and depression scale factor structure in adolescents and young adults with cystic fibrosis: a confirmatory factor analysis. J Pediatr Psychol. 2018;43(6):625–35. https://doi.org/10.1093/jpepsy/jsx155.CrossRefPubMed

65.

Berard R, Ahmed N. Hospital anxiety and depression scale (HADS) as a screening instrument in a depressed adolescent and young adult population. Int J Adolesc Med Health. 1995;8:157–66.

66.

Heijnders M, van der Meij S. The fight against stigma: an overview of stigma-reduction strategies and interventions. Psychol Health Med. 2006;11(3):353–63. https://doi.org/10.1080/13548500600595327.CrossRefPubMed

67.

Lai J-S, Jensen SE, Charrow J, Listernick R. Patient reported outcomes measurement information system and quality of life in neurological disorders measurement system to evaluate quality of life for children and adolescents with neurofibromatosis type 1 associated plexiform neurofibroma. J Pediatr. 2019;206:190–6. https://doi.org/10.1016/j.jpeds.2018.10.019.CrossRefPubMed

68.

Alansari R, Bedos C, Allison P. Living with cleft lip and palate: the treatment journey. Cleft Palate Craniofac J. 2014;51(2):222–9. https://doi.org/10.1597/12-255.CrossRefPubMed

69.

Ablon J. The nature of stigma and medical conditions. Epilepsy Behav. 2002;3:S2–9.CrossRef

70.

Krueckeberg SM, Kapp-Simon K. Effect of parental factors on social skills of preschool children with craniofacial anomalies. Cleft Palate Craniofac J. 1993;30(5):490–6. https://doi.org/10.1597/1545-1569_1993_030_0490_eopfos_2.3.co_2.CrossRefPubMed

71.

Carroll L, Graff C, Wicks M, Diaz Thomas A. Living with an invisible illness: a qualitative study exploring the lived experiences of female children with congenital adrenal hyperplasia. Qual Life Res. 2020;29(3):673–81. https://doi.org/10.1007/s11136-019-02350-2.CrossRefPubMed

72.

Francis A. Stigma in an era of medicalisation and anxious parenting: how proximity and culpability shape middle-class parents’ experiences of disgrace: stigma in an era of medicalisation and anxious parenting. Sociol Health Illn. 2012;34(6):927–42. https://doi.org/10.1111/j.1467-9566.2011.01445.x.CrossRefPubMed

73.

Manago B, Davis JL, Goar C. Discourse in action: parents’ use of medical and social models to resist disability stigma. Soc Sci Med. 2017;184:169–77. https://doi.org/10.1016/j.socscimed.2017.05.015.CrossRefPubMed

74.

Fleitas J. Sticks, stones, and the stigmata of childhood illness and disability. Reclaiming Child Youth. 2000;9:146–9.

75.

Landsman GH. Reconstructing motherhood in the age of “perfect” babies: mothers of infants and toddlers with disabilities. Signs. 1998;24:69–99.CrossRef

76.

Bessell A, Brough V, Clarke A, Harcourt D, Moss TP, Rumsey N. Evaluation of the effectiveness of Face IT, a computer-based psychosocial intervention for disfigurement-related distress. Psychol Health Med. 2012;17(5):565–77. https://doi.org/10.1080/13548506.2011.647701.CrossRefPubMed

77.

Yanos PT, Roe D, Lysaker PH. Narrative enhancement and cognitive therapy: a new group-based treatment for internalized stigma among persons with severe mental illness. Int J Group Psychother. 2011;61(4):577–95. https://doi.org/10.1521/ijgp.2011.61.4.576.CrossRefPubMed

78.

Mittal D, Sullivan G, Chekuri L, Allee E, Corrigan PW. Empirical studies of self-stigma reduction strategies: a critical review of the literature. Psychiatr Serv. 2012;63(10):974–81. https://doi.org/10.1176/appi.ps.201100459.CrossRefPubMed

79.

Pearl RL, Hopkins CH, Berkowitz RI, Wadden TA. Group cognitive-behavioral treatment for internalized weight stigma: a pilot study. Eat Weigh Disord. 2016;27:1–6.

80.

Hansson L, Yanos PT. Narrative enhancement and cognitive therapy: a pilot study of Outomes of a self-stigma intervention in a Swedish clinical context. Stigma Health. 2016;1(4):280–6. https://doi.org/10.1037/sah0000035.CrossRef

81.

KappSimon KA, McGuire DE. Observed social interaction patterns in adolescents with and without craniofacial conditions. Cleft Palate Craniofac J. 1997;34(5):380–4. https://doi.org/10.1597/1545-1569_1997_034_0380_osipia_2.3.co_2.CrossRef

82.

Rumsey N, Harcourt D. Visible difference amongst children and adolescents: issues and interventions. Dev Neurorehabil. 2007;10(2):113–23. https://doi.org/10.1080/13638490701217396.CrossRefPubMed

83.

Maddern LH, Cadogan JC, Emerson MP. “Outlook”: a psychological service for children with a different appearance. Cleft Palate Craniofac J. 2006;11:431–43.

84.

Waugh OC, Byrne DG, Nicholas MK. Internalized stigma in people living with chronic pain. J Pain. 2014;15:550.e1–550.e10.CrossRef

85.

Sheng J, Liu S, Wang Y, Cui R, Zhang X. The link between depression and chronic pain: neural mechanisms in the brain. Neural Plast. 2017;2017:1–10. https://doi.org/10.1155/2017/9724371.CrossRef

86.

Naushad N, Dunn LB, Muñoz RF, Leykin Y. Depression increases subjective stigma of chronic pain. J Affect Disord. 2018;229:456–62. https://doi.org/10.1016/j.jad.2017.12.085.CrossRefPubMedPubMedCentral

87.

Coyne JC, van Sonderen E. The hospital anxiety and depression scale (HADS) is dead, but like Elvis, there will still be citings. J Psychosom Res. 2012;73(1):77–8. https://doi.org/10.1016/j.jpsychores.2012.04.002.CrossRef

88.

Polich GR. Rare disease patient groups as clinical researchers. Drug Discov Today. 2012;17:167–72.CrossRef

89.

Panofsky A, Huyard C, Polich GR, Popoviciu S, Birle D, Olah S, et al. Generating sociability to drive science: patient advocacy organizations and genetics research. Soc Stud Sci. 2008;41:52 17; 36; 7; 11; 31:31; 719; 167; 144; A136; 21–57; +; 172; 161; A137; 29.

90.

Huyard C, Polich GR, Popoviciu S, Birle D, Olah S, Popoviciu I. Who rules rare disease associations? A framework to understand their action. Sociol Health Illn. 2012;17:36 979; 167; 144–72; 161.

Title: Stigma and psychological distress among pediatric participants in the FD/MAS Alliance Patient Registry
Author: Amanda Konradi
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Mood Disorders
McCune-Albright syndrome
Affective Disorder
Anxiety
Published in: BMC Pediatrics / Issue 1/2021
Electronic ISSN: 1471-2431
DOI: https://doi.org/10.1186/s12887-021-02647-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Stigma and psychological distress among pediatric participants in the FD/MAS Alliance Patient Registry

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Treatment device for neonatal birth asphyxia related Hypoxic Ischemic Encephalopathy

Retinal vein occlusion with cerebral infarction in a preterm neonate: a case report

Osteomyelitis in Immunocompromised children and neonates, a case series

Improvement in BMI z-score following adenotonsillectomy in adolescents aged 12–18 years: a retrospective cohort study

Waitlist management in a pediatric weight management clinic: implementing an orientation session

Stapled versus hand-sewn intestinal anastomosis in pediatric patients: a systematic review and meta-analysis